Solid Biosciences Inc.
SLDB
39 insider filings · Latest: Jun 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Jan 30 9:05 PM | Ilan GanotDirector | Sale | 191 | $6.59 | $1.3K | 17,476(I) | View → |
| Jan 13, 2026 | Jan 13 10:00 PM | Tan Kevin | Proposed Sale | 5,704 | $5.27 | $30.1K | — | View → |
| Dec 3, 2025 | Dec 3 10:07 PM | Cumbo Alexander | Proposed Sale | 10,808 | $5.11 | $55.2K | — | View → |
| Feb 14, 2025 | Feb 14 10:25 PM | Howton David T | Proposed Sale | 5,561 | $3.96 | $22.0K | — | View → |
| Feb 14, 2025 | Feb 14 10:25 PM | Herzich Paul | Proposed Sale | 2,688 | $3.96 | $10.6K | — | View → |
| Feb 14, 2025 | Feb 14 10:23 PM | Tan Kevin | Proposed Sale | 3,164 | $3.96 | $12.5K | — | View → |
| Feb 14, 2025 | Feb 14 10:23 PM | Cumbo Alexander | Proposed Sale | 11,365 | $3.96 | $45.0K | — | View → |
| Feb 14, 2025 | Feb 14 10:20 PM | Hanrahan Jessie | Proposed Sale | 3,079 | $3.96 | $12.2K | — | View → |
| Dec 3, 2024 | Dec 5 9:05 PM | Cumbo Alexander | Proposed Sale | 11,114 | $5.60 | $62.2K | — | View → |
| Dec 3, 2024 | Dec 4 10:33 PM | Howton David T | Proposed Sale | 5,072 | $5.60 | $28.4K | — | View → |
| Dec 3, 2024 | Dec 3 10:35 PM | Cumbo Alexander | Proposed Sale | 10,687 | $5.79 | $61.9K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 19 2:31 AM | Paul HerzichChief Technology Officer | Option Exercise | 7,187 | — | 14,376(D) | View → |
| Feb 13, 2026 | Feb 19 2:31 AM | David T HowtonChief Operating Officer | Option Exercise | 14,687 | — | 29,376(D) | View → |
| Feb 13, 2026 | Feb 19 2:28 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 10,937 | — | 21,876(D) | View → |
| Feb 13, 2026 | Feb 19 2:25 AM | Kevin TanCFO & Treasurer | Option Exercise | 10,625 | — | 21,250(D) | View → |
| Jan 31, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Option Exercise | 33,075 | — | 99,225(D) | View → |
| Jan 29, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Option Exercise | 56,646 | — | 0(D) | View → |
| Jan 29, 2026 | Feb 3 1:18 AM | Kevin TanCFO & Treasurer | Grant/Award | 280,500 | $6.60 | 93,500(D) | View → |
| Jan 31, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Option Exercise | 100,400 | — | 301,200(D) | View → |
| Jan 29, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Grant/Award | 764,750 | $6.60 | 254,900(D) | View → |
| Jan 29, 2026 | Feb 3 1:16 AM | Alexander CumboDirector, President and CEO | Option Exercise | 169,401 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Option Exercise | 27,625 | — | 82,875(D) | View → |
| Jan 29, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Grant/Award | 285,000 | $6.60 | 95,000(D) | View → |
| Jan 29, 2026 | Feb 3 1:15 AM | Jessie HanrahanChief Regulatory Officer | Option Exercise | 54,925 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 28,225 | — | 84,675(D) | View → |
| Jan 29, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Grant/Award | 311,200 | $6.60 | 103,750(D) | View → |
| Jan 29, 2026 | Feb 3 1:14 AM | Gabriel BrooksChief Medical Officer | Option Exercise | 58,847 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:12 AM | David T HowtonChief Operating Officer | Option Exercise | 42,275 | — | 126,825(D) | View → |
| Jan 29, 2026 | Feb 3 1:12 AM | David T HowtonChief Operating Officer | Grant/Award | 315,300 | $6.60 | 105,100(D) | View → |
| Jan 29, 2026 | Feb 3 1:12 AM | David T HowtonChief Operating Officer | Option Exercise | 79,341 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 1:09 AM | Paul HerzichChief Technology Officer | Option Exercise | 24,675 | — | 74,025(D) | View → |